超声介入治疗不典型肝脓肿的效果及预后分析OA
Efficacy and Prognosis of Ultrasound-Guided Interventional Treatment for Atypical Liver Abscess
目的 比较分析超声引导下经皮穿刺针抽吸术(PNA)和经皮置管引流术(PCD)治疗不典型肝脓肿的临床疗效及预后差异.方法 回顾性纳入郑州大学附属郑州中心医院 2021 年 7 月至 2024 年 6 月收治的 90 例不典型肝脓肿患者,根据介入引流术式分为PNA组(42 例)和PCD组(48 例).两组患者均在广谱抗生素治疗基础上分别接受PNA或置管PCD引流治疗,监测比较术后肝功能指标[天门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)和总胆红素(TBil)]、炎症指标[C反应蛋白(CRP)、降钙素原(PCT)以及系统性免疫炎症指数(SⅡ)]在术后 7 天、术后 1 个月、术后 12 个月的变化,评估临床疗效并记录并发症情况.结果 治疗 1 个月后,PCD组的显效病例比例更高(75.00%vs54.76%),无效/复发比例更低(2.08%vs9.52%),两组患者的治疗效果分布比较,差异有统计学意义(P<0.05).治疗前,两组患者的CRP、PCT和SⅡ水平比较,差异无统计学意义(P>0.05).重复测量方差分析显示,各指标均存在显著的时间主效应(P<0.05),表明治疗后水平均随时间显著下降.两两比较发现,PCD组在治疗后 7 天降低CRP、PCT和SⅡ的效果均显著优于PNA组(P<0.05);而在治疗后 1 个月及 12 个月,两组间各指标的差异均无统计学意义(P>0.05).治疗前,两组患者的AST、ALT和TBil水平比较,差异无统计学意义(P>0.05).重复测量方差分析显示,各指标均存在显著的时间主效应(P<0.05),表明治疗后水平均随时间显著下降.分析同时发现,三项指标均存在显著的时间与组别的交互效应(P<0.05).两两比较发现,PCD组在治疗后 7 天降低AST、ALT和TBil的效果均显著优于PNA组(P<0.05);而在治疗后 1 个月及 12 个月,两组间各指标的差异均无统计学意义(P>0.05).此外,三项指标的组间主效应均无统计学意义(P>0.05).PNA组患者治疗后随访期间,有 4 例患者出现肝脓肿复发,2 例患者存在出血,并发症发生率为 14.29%(6/42);PCD组患者有 1 例患者出现肝脓肿复发,2 例患者存在腹部疼痛,并发症发生率为6.25%(3/48).两组患者并发症发生率比较,差异无统计学意义(χ2=0.838,P=0.360).结论 对于不典型肝脓肿,在规范抗生素治疗基础上采用超声引导下PNA或PCD均能取得良好疗效和远期预后,PCD可有效地持续引流脓液,加速感染控制和肝功能恢复,在术后短期内提高临床显效率.
Objective To compare the clinical efficacy and prognostic outcomes of ultrasound-guided percutaneous needle aspiration(PNA)and percutaneous catheter drainage(PCD)in the treatment of atypical liver abscess.Methods This retrospective study included 90 patients with atypical liver abscess admitted to Zhengzhou Central Hospital Affiliated to Zhengzhou University from July 2021 to June 2024.According to the interventional drainage technique,the patients were assigned to the PNA group(n=42)and the PCD group(n=48).On the basis of broad-spectrum antibiotic therapy,patients in the two groups received PNA or catheter-based PCD drainage,respectively.Postoperative changes in liver function indices[aspartate aminotransferase(AST),alanine aminotransferase(ALT),and total bilirubin(TBil)]and inflammatory indices[C-reactive protein(CRP),procalcitonin(PCT),and systemic immune-inflammation index(S Ⅱ)]were monitored and compared at 7 days,1 month,and 12 months after the procedure.Clinical efficacy was evaluated,and complications were recorded.Results At 1 month after treatment,the PCD group had a higher proportion of markedly effective cases(75.00%vs 54.76%)and a lower proportion of ineffective/relapsed cases(2.08%vs 9.52%).The distribution of treatment responses differed significantly between the two groups(P<0.05).Before treatment,there were no statistically significant differences between the two groups in CRP,PCT,or SⅡ levels(P>0.05).Repeated-measures analysis of variance showed significant main effects of time for all indices(P<0.05),indicating that levels decreased significantly over time after treatment.Pairwise comparisons showed that the reductions in CRP,PCT,and S Ⅱ at 7 days after treatment were significantly greater in the PCD group than in the PNA group(P<0.05),whereas no statistically significant differences were observed between the two groups at 1 month and 12 months after treatment(P>0.05).Before treatment,there were no statistically significant differences between the two groups in AST,ALT,or TBil levels(P>0.05).Repeated-measures analysis of variance showed significant main effects of time for all liver function indices(P<0.05),indicating significant decreases over time after treatment.In addition,significant time-by-group interaction effects were observed for all three indices(P<0.05).Pairwise comparisons showed that the reductions in AST,ALT,and TBil at 7 days after treatment were significantly greater in the PCD group than in the PNA group(P<0.05),whereas no statistically significant differences were found between the two groups at 1 month and 12 months after treatment(P>0.05).Moreover,the main effects of group were not statistically significant for these three indices(P>0.05).During follow-up after treatment,in the PNA group,4 patients experienced recurrence of liver abscess and 2 patients developed bleeding,with a complication rate of 14.29%(6/42).In the PCD group,1 patient experienced recurrence of liver abscess and 2 patients reported abdominal pain,with a complication rate of 6.25%(3/48).The difference in complication rates between the two groups was not statistically significant(χ²=0.838,P=0.360).Conclusion For atypical liver abscess,both ultrasound-guided PNA and PCD on the basis of standardized antibiotic therapy can achieve favorable efficacy and long-term prognosis.PCD can provide continuous drainage of pus,accelerate infection control and recovery of liver function,and improve the short-term markedly effective rate.
张春霞;崔智飞
郑州大学附属郑州中心医院 超声医学科,河南 郑州 450000郑州大学附属郑州中心医院 超声医学科,河南 郑州 450000
医药卫生
不典型肝脓肿经皮穿刺抽吸术经皮置管引流术超声引导预后
atypical liver abscesspercutaneous needle aspirationpercutaneous catheter drainageultrasound guidanceprognosis
《临床研究》 2026 (1)
58-62,5
评论